Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1982 Nov;77(3):449–454. doi: 10.1111/j.1476-5381.1982.tb09317.x

alpha-Adrenoceptor blocking properties of raubasine in pithed rats.

P Demichel, P Gomond, J Roquebert
PMCID: PMC2044614  PMID: 6128043

Abstract

1 Raubasine was compared with yohimbine and corynanthine in pithed rats. Antagonist activity at alpha 1-adrenoceptors was evaluated on the pressor response to electrical stimulation of the spinal sympathetic outflow and to phenylephrine administration, both being reduced by raubasine in the dose range 1 to 4 mg/kg. Corynanthine was quantitatively similar, but yohimbine was not only less potent but also in doses of 0.125 to 0.5 mg/kg enhanced the effects of electrical stimulation. 2 Antagonist activity at alpha 2-adrenoceptors was determined against the inhibitory effects of clonidine on tachycardia induced by electrical stimulation of cardiac sympathetic nerves and against the pressor responses to B-HT-933 injection. Raubasine up to 4 mg/kg, like corynanthine, did not affect the pressor responses to B-HT-933 nor did it reduce the inhibitory effect of clonidine. By contrast yohimbine reduced the response to BHT-933 and antagonized clonidine as well as enhancing the tachycardia caused by electrical stimulation. 3 The results indicate that, in vivo, raubasine, like corynanthine, is a selective antagonist at alpha 1-adrenoceptors and that yohimbine is more potent in blocking alpha 2-than alpha 1-adrenoceptors.

Full text

PDF
449

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong J. M., Boura A. L. Effects of clonidine and guanethidine on peripheral sympathetic nerve function in the pithed rat. Br J Pharmacol. 1973 Apr;47(4):850–852. doi: 10.1111/j.1476-5381.1973.tb08214.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berthelsen S., Pettinger W. A. A functional basis for classification of alpha-adrenergic receptors. Life Sci. 1977 Sep 1;21(5):595–606. doi: 10.1016/0024-3205(77)90066-2. [DOI] [PubMed] [Google Scholar]
  3. Demichel P., Gomond P., Roquebert J. Pre- and postsynaptic alpha-adrenoceptor blocking activity of raubasine in the rat vas deferens. Br J Pharmacol. 1981 Dec;74(4):739–745. doi: 10.1111/j.1476-5381.1981.tb10706.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Docherty J. R., MacDonald A., McGrath J. C. Further sub-classification of alpha-adrenoceptors in the cardiovascular system, vas deferens and anococcygeus of the rat [proceedings]. Br J Pharmacol. 1979 Nov;67(3):421P–422P. [PMC free article] [PubMed] [Google Scholar]
  5. Docherty J. R., McGrath J. C. A comparison of pre- and post-junctional potencies of several alpha-adrenoceptor agonists in the cardiovascular system and anococcygeus muscle of the rat. Evidence for two types of post-junctional alpha-adrenoceptor. Naunyn Schmiedebergs Arch Pharmacol. 1980 Jun;312(2):107–116. doi: 10.1007/BF00569718. [DOI] [PubMed] [Google Scholar]
  6. Gillespie J. S., Muir T. C. A method of stimulating the complete sympathetic outflow from the spinal cord to blood vessels in the pithed rat. Br J Pharmacol Chemother. 1967 May;30(1):78–87. doi: 10.1111/j.1476-5381.1967.tb02114.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. KRONEBERG G. Pharmakologie des Rauwolfia-Alkaloids Raubasin (gamma-Yohimbin-Ajmalicin). Naunyn Schmiedebergs Arch Exp Pathol Pharmakol. 1958;233(1):72–97. [PubMed] [Google Scholar]
  8. Kobinger W., Pichler L. Pharmacological characterization of B-HT 933 (2-amino-6-ethyl-4,5,7,8,-tetrahydro-6H-oxazolo-[5,4-d]-azepindihydrochloride) as a hypotensive agent of the "clonidine-type". Naunyn Schmiedebergs Arch Pharmacol. 1977 Oct;300(1):39–46. doi: 10.1007/BF00505078. [DOI] [PubMed] [Google Scholar]
  9. Langer S. Z. Presynaptic regulation of catecholamine release. Biochem Pharmacol. 1974 Jul 1;23(13):1793–1800. doi: 10.1016/0006-2952(74)90187-7. [DOI] [PubMed] [Google Scholar]
  10. Pichler L., Placheta P., Kobinger W. Effect of azepexole (B-HT 933) on pre- and postsynaptic alpha-adrenoceptors at peripheral and central nervous sites. Eur J Pharmacol. 1980 Jul 25;65(2-3):233–241. doi: 10.1016/0014-2999(80)90396-9. [DOI] [PubMed] [Google Scholar]
  11. Roquebert J., Gomond P., Demichel P. Activité antinoradrénergique de la raubasine sur l'aorte thoracique et le canal déférent isolés de rat. J Pharmacol. 1981 Nov-Dec;12(4):393–403. [PubMed] [Google Scholar]
  12. Starke K., Endo T., Taube H. D. Relative pre- and postsynaptic potencies of alpha-adrenoceptor agonists in the rabbit pulmonary artery. Naunyn Schmiedebergs Arch Pharmacol. 1975;291(1):55–78. doi: 10.1007/BF00510821. [DOI] [PubMed] [Google Scholar]
  13. Starke K. Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol. 1977;77:1–124. doi: 10.1007/BFb0050157. [DOI] [PubMed] [Google Scholar]
  14. Timmermans P. B., Van Zwieten P. A. Postsynaptic alpha 1- and alpha 2-adrenoceptors in the circulatory system of the pithed rat: selective stimulation of the alpha 2-type by B-HT 933. Eur J Pharmacol. 1980 May 2;63(2-3):199–202. doi: 10.1016/0014-2999(80)90446-x. [DOI] [PubMed] [Google Scholar]
  15. Weitzell R., Tanaka T., Starke K. Pre- and postsynaptic effects of yohimbine stereoisomers on noradrenergic transmission in the pulmonary artery of the rabbit. Naunyn Schmiedebergs Arch Pharmacol. 1979 Aug;308(2):127–136. doi: 10.1007/BF00499054. [DOI] [PubMed] [Google Scholar]
  16. Yamaguchi I., Kopin I. J. Differential inhibiton of alpha-1 and alpha-2 adrenoceptor-mediated pressor responses in pithed rats. J Pharmacol Exp Ther. 1980 Aug;214(2):275–281. [PubMed] [Google Scholar]
  17. Yamaguchi I., Kopin I. J. Plasma catecholamine and blood pressure responses to sympathetic stimulation in pithed rats. Am J Physiol. 1979 Sep;237(3):H305–H310. doi: 10.1152/ajpheart.1979.237.3.H305. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES